Rahmer Peter's Form 4 filing
Relay Therapeutics, Inc. (RLAY) · filed Jul 30, 2025
- Accession no.
- 0000950170-25-100367
- Filed
- Jul 30, 2025
- Trade date
- Jul 28-29, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $62.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rahmer PeterCIK 0001959229 | Officer (See remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 28, 2025 | Common Stock | SSaleDisposed | −1,359 | $3.74 | −$5,082.66 | 393,722 | Direct | |
| Jul 29, 2025 | Common Stock | SSaleDisposed | −15,724 | $3.68 | −$57,864.32 | 377,998 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.